How Oncologists and Pathologists Can Best Collaborate to Provide Precision Medicine for Their Patients

David Spigel, MD

Video Categories: 2018 ASCO Insights and Video Library

Dr David Spigel discusses how medical oncologists and the rest of the cancer care team can best communicate with pathologists to help make informed treatment decisions for individual patients and set up new assays for emerging biomarkers as they are discovered.

July 13, 2021

Recommendations for Mutational Analysis of Various Solid Tumors

Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler Rush of University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, explain which targetable mutation should be screened for various solid tumors.

October 16, 2015

The Role of Anti-PD-1 Antibodies

Dr. Sanjiv Agarwala addresses the possibility of updating indications for Nivolumab and Pembrolizumab in the therapeutic arena.